- Little Green Pharma (LGP) announces a leadership change, with CEO, Fleta Solomon, stepping aside at the end of August
- The company’s current COO, Paul Long, is elected by the board to take Ms Solomon’s place
- Ms Solomon will stay on as a member of the board with a part-time executive role
- Incoming CEO Paul Long has been with the company for five years
- LGP shares last traded at 18.5 cents
Little Green Pharma (LGP) has announced a leadership change, with the current Chief Executive Officer, Fleta Solomon, stepping aside at the end of August.
The company’s current Chief Operating Officer, Paul Long, has been selected by the board to succeed Ms. Solomon.
Ms Solomon, the founder of LGP, has played a pivotal role in driving the company’s success and growth in the cannabis industry.
She will continue to serve on the company’s board in a part-time executive capacity, focusing on external communications, market positioning, ESG, and branding.
“After seven years in the role as CEO, living and breathing Little Green Pharma, I’ve elected to reduce my workload and focus increasingly on those parts of the LGP business I’m most passionate about,” she said.
“While this is a difficult decision personally, it was made much easier knowing we have a ready-made replacement in our COO Paul Long.”
The incoming CEO, Mr Long, has been with LGP for more than five years, playing a significant role in managing internal operations and strategic activities for the company.
LGP shares last traded at 18.5 cents.